Case Page


Case Status:    SETTLED
On or around 09/30/2003 (Date of order of final judgment)

Filing Date: December 02, 1999

On February 6, 2003, the Court entered the Order granting the plaintiff’s motion for class certification. On July 16, 2003, a Stipulation of Settlement was filed. On September 20, 2003, the Court entered the Order approving the settlement of $6,350,000 and dismissing the action with prejudice. The plaintiff’s counsel was further awarded attorney fees and reimbursement of expenses. On December 13, 2004, the Court entered the Settlement Distribution Order.

According to a press release dated May 31, 2002, on May 30, 2002 the United States Court of Appeals for the Third Circuit reversed the dismissal of a securities fraud class action filed against Roche Holding Ltd. (Pink Sheets:RHHBY), brought on behalf of ADR purchasers during the period December 3, 1996 through May 20, 1999 ("class period"). The lawsuit alleges that the trading prices for Roche Holding ADRs were artificially inflated by false and/or misleading statements concerning the competitive market for certain Roche products. The truth became known in May 1999 when Roche Holding's primary subsidiary as well as a Roche Holding officer pled guilty to participation in a price fixing conspiracy in violation of U.S. antitrust laws. The court of appeals found that plaintiff adequately pled reliance upon Roche Holding's misrepresentations, and rejected the contention that Roche Holding, a Swiss corporation, is not amenable to personal jurisdiction in the United States for claims filed by purchasers of ADRs.

By order dated November 13, 2000, the Court dismissed the complaint. The dismissal was without prejudice.

On March 15, 2000, the law firm of Kirby McInerney & Squire, LLP, was appointed lead counsel in a securities class action lawsuit.

The complaint asserted that Roche's ADRs traded at artificially inflated prices throughout the period described above, due to Roche's engaging in illegal price-fixing and anti-competitive practices in violation of U.S. anti-trust laws, which artificially inflated Roche's earnings and the prices of the ADRs. On May 19, 1999, it was announced that Roche's primary operating subsidiary and certain of Roche's officers had pled guilty to violating Unites States antitrust laws; Roche's operating subsidiary paid $500 million in fines.


Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: Switzerland


Ticker Symbol: RHHBY
Company Market: Pink Sheets
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. New Jersey
DOCKET #: 99-CV-05627
JUDGE: Hon. John W. Bissell
DATE FILED: 12/02/1999
CLASS PERIOD END: 05/20/1999
  1. Kirby McInerney & Squire LLP
    830 Third Avenue 10th Floor, Kirby McInerney & Squire LLP, NY 10022
    212.317.2300 ·
No Document Title Filing Date
No Document Title Filing Date